Ulcerative colitis, UC, is one of the 2 major forms of inflammatory bowel disease.
In UC, the inner lining of the large intestine is inflamed, causing open sores, or ulcers.
UC usually affects only the mucosa and submucosa layers of the intestinal wall.
The condition evolves in the form of recurrent flares, when new lesions form, followed by
symptom-free periods of remission, when these lesions heal.
Typical symptoms include abdominal pain and persistent diarrhea, often with mucus and/or
blood.
Some patients may experience fecal urgency, fecal incontinence, or tenesmus – the inability
to move bowels in spite of the urge.
The disease also often manifests outside the intestine, as a result of inflammation of
joints, skin, and eyes.
Severe cases can present with systemic symptoms such as weight loss, nausea, vomiting, fatigue
and fever.
UC usually starts from the lower end of the large intestine, and may remain limited to
that location; or, it can spread upward and affect more of the colon, sometimes the entire
colon.
The disease is mildest when it is confined to the lower part of the bowel, in which case
the main symptom is blood and mucus in stools, but the stools can be of normal consistency.
Once the disease progresses to upper colon, stools become more watery, sometimes consist
entirely of blood and mucus.
The patient may have multiple bowel movements per day, often with severe cramps and tenesmus.
In the long-term, UC may increase risks for colon cancers, but the most dangerous complication
to watch out for is toxic colitis, or fulminant colitis, a life-threatening condition characterized
by sudden violent diarrhea, high fever, abdominal pain, and signs of peritonitis.
Toxic colitis occurs when inflammation extends into the smooth muscle layer of the intestinal
wall, paralyzing the colon muscle.
This may lead to colon dilatation, and sometimes perforation.
UC has 2 incidence peaks: one major peak in teens and young adults, and a smaller peak
after the age of 50.
Some races are more susceptible than others.
Family history of the disease is also a risk factor.
Ulcerative colitis is a chronic inflammatory disease, where the ongoing immune response
destroys the body’s own tissues.
It is associated with abnormally high levels of T-helper cell response, specifically helper
T-cell type 2, Th-2.
The exact mechanism is not fully understood, but it likely involves both genetic and environmental
factors.
Multiple genes are identified, most of which act in the immune system, or in maintaining
the gastrointestinal epithelial barrier.
A mutation in any of these genes may weaken the body’s ability to regulate the extent
of immune responses, or to differentiate between self and non-self.
An appropriate inflammatory response against a pathogen may get out of control and become
chronic; or, the body may mount an inappropriate response against its own antigens.
Involvement of environmental factors is evidenced by higher rates of UC in developed countries,
especially urban areas.
Interestingly, smoking seems to have a protective effect.
Diagnosis is mostly based on symptoms, but tests are done to exclude other causes: stool
tests to exclude infections, colonoscopy to rule out cancers.
Treatments include: Dietary management to maintain good nutrition
but avoid foods that may cause discomfort.
Diarrhea medications to relieve symptoms, except in case of severe attacks.
Mild to moderate patients are prescribed topical or oral 5-Aminosalicylic acid, depending on
the affected locations.
Extensive UC is treated with corticosteroids, immunomodulators and biologics.
Severe cases are hospitalized and managed with intravenous corticosteroids; patients
are observed closely for development of toxic colitis.
Toxic colitis is treated with high-dose intravenous corticosteroids and antibiotics, and may require
emergency surgery.
Some patients with extensive disease may ultimately need surgery to remove the affected part of
the colon.
Surgery essentially cures the disease.